Inactive Instrument

Morison PLC

MORI.N0000

LK0091N00005

J.L. Morison Sons & Jones PLC Announces the Resignation of Asoka Abeyewardene as Independent Non-Executive Director

November 24, 2016

J.L. Morison Sons & Jones (Ceylon) PLC announced the resignation of Asoka Abeyewardene as independent non-executive director from the board, with effect from November 24, 2016.

Latest news about Morison PLC

Morison Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-22	CI
Morison Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-23	CI
Morison PLC Appoints Sanjit Singh Lamba as Independent Non-Executive Director	20-09-03	CI
Morison plc Reports Earnings Results for the First Quarter Ended June 30, 2020	20-08-08	CI
Morison PLC Appoints Sanjit Singh Lamba as Independent Non-Executive Director, Effective September 1, 2020	20-07-09	CI
Morison PLC Announces Retirement of Steven Mark Enderby as Non Independent Non Executive Director, Effective September 30, 2020	20-06-24	CI
Morison plc Reports Earnings Results for the Full Year Ended March 31, 2020	20-05-29	CI
Morison plc Reports Earnings Results for the Third Quarter Ended December 31, 2019	20-02-12	CI
Morison PLC Reports Earnings Results for the Second Quarter Ended September 30, 2019	19-10-25	CI
Morison plc Reports Earnings Results for the First Quarter Ended June 30, 2019	19-07-23	CI
Morison plc Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	19-05-17	CI
Morison plc Reports Earnings Results for the Third Quarter Ended December 31, 2018	19-01-25	CI
Morison PLC Announces Company and Group Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	18-11-05	CI
Morison PLC Appoints Ahmed Zalmi Fazeel as a Non-Independent Non-Executive Director	18-09-03	CI
Ravindra Fernando Resigns from the Board of Directors of Morison plc	18-06-03	CI
Morison PLC Reports Group and Company Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2018	18-05-24	CI
Morison plc Announces Interim Dividend for Fiscal 2018, Payable on March 29, 2018	18-03-09	CI
Morison PLC Reports Group and Company Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017	18-01-26	CI
Morison PLC Appoints Kasturi Chellaraja Wilson as Non-Independent Non-Executive Director	18-01-04	CI
J. L. Morison Son & Jones PLC Reports Audited Group and Company Earnings Results for the First Quarter Ended June 30, 2017	17-08-01	CI
J. L. Morison Son & Jones PLC Reports Group and Company Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2017	17-05-16	CI
J. L. Morison Son & Jones PLC Proposes Final Dividend for the Fiscal Year 2017 Payable on July 4, 2017	17-05-16	CI
J. L. Morison Son & Jones PLC Announces Interim Dividend for Financial Year 2016-2017 Payable on March 28, 2017	17-03-08	CI
J. L. Morison Sons & Jones PLC Reports Group and Company Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016	17-02-13	CI
J.L. Morison Sons & Jones PLC Announces the Resignation of Asoka Abeyewardene as Independent Non-Executive Director	16-11-24	CI

Morison PLC., formerly J.L. Morison Son & Jones (Ceylon) PLC, is a Sri Lanka-based pharmaceutical manufacturer. In addition to manufacturing pharmaceutical and over-the-counter (OTC) products, the Company is also engaged in importing and distribution of healthcare and consumer products. It is engaged in the trading in manufacturing, importing and distribution of pharmaceuticals, medical aid, hair care products, diagnostics reagent and equipment and other consumer products. The Company's OTC and consumer category includes brands, such as Morison's Lacto Calamine, Morison's Gripe Mixture and Valmelix Cough Syrup.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals